These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 31313390)
1. The comparative effectiveness of fourth-line drugs in resistant hypertension: An application in electronic health record data. Sinnott SJ; Smeeth L; Williamson E; Perel P; Nitsch D; Tomlinson LA; Douglas IJ Pharmacoepidemiol Drug Saf; 2019 Sep; 28(9):1267-1277. PubMed ID: 31313390 [TBL] [Abstract][Full Text] [Related]
2. Comparative effectiveness of fourth-line anti-hypertensive agents in resistant hypertension: A systematic review and meta-analysis. Sinnott SJ; Tomlinson LA; Root AA; Mathur R; Mansfield KE; Smeeth L; Douglas IJ Eur J Prev Cardiol; 2017 Feb; 24(3):228-238. PubMed ID: 27856806 [TBL] [Abstract][Full Text] [Related]
3. Comparative Safety and Effectiveness of Aldosterone Antagonists Versus Beta-Blockers as Fourth Agents in Patients With Apparent Resistant Hypertension. Desai R; Park H; Brown JD; Mohandas R; Pepine CJ; Smith SM Hypertension; 2022 Oct; 79(10):2305-2315. PubMed ID: 35880517 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological intervention in hypertension using beta-blockers: Real-world evidence for long-term effectiveness. Sabidó M; Hohenberger T; Grassi G Pharmacol Res; 2018 Apr; 130():191-197. PubMed ID: 29366925 [TBL] [Abstract][Full Text] [Related]
5. The Role of Beta-Blockers in the Treatment of Hypertension. Cruickshank JM Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711 [TBL] [Abstract][Full Text] [Related]
6. Outcomes with Angiotensin-converting Enzyme Inhibitors vs Other Antihypertensive Agents in Hypertensive Blacks. Bangalore S; Ogedegbe G; Gyamfi J; Guo Y; Roy J; Goldfeld K; Torgersen C; Capponi L; Phillips C; Shah NR Am J Med; 2015 Nov; 128(11):1195-203. PubMed ID: 26071821 [TBL] [Abstract][Full Text] [Related]
10. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group. JAMA; 2000 Apr; 283(15):1967-75. PubMed ID: 10789664 [TBL] [Abstract][Full Text] [Related]
11. The risk of myocardial infarction associated with antihypertensive drug therapies. Psaty BM; Heckbert SR; Koepsell TD; Siscovick DS; Raghunathan TE; Weiss NS; Rosendaal FR; Lemaitre RN; Smith NL; Wahl PW JAMA; 1995 Aug 23-30; 274(8):620-5. PubMed ID: 7637142 [TBL] [Abstract][Full Text] [Related]
12. Characteristics and treatment of African-American and European-American patients with resistant hypertension identified using the electronic health record in an academic health centre: a case-control study. Shuey MM; Gandelman JS; Chung CP; Nian H; Yu C; Denny JC; Brown NJ BMJ Open; 2018 Jun; 8(6):e021640. PubMed ID: 29950471 [TBL] [Abstract][Full Text] [Related]
13. Kidney, Cardiac, and Safety Outcomes Associated With α-Blockers in Patients With CKD: A Population-Based Cohort Study. Hundemer GL; Knoll GA; Petrcich W; Hiremath S; Ruzicka M; Burns KD; Edwards C; Bugeja A; Rhodes E; Sood MM Am J Kidney Dis; 2021 Feb; 77(2):178-189.e1. PubMed ID: 32920153 [TBL] [Abstract][Full Text] [Related]
14. Does Angiotensin-Converting Enzyme Inhibitor and β-Blocker Use Reduce the Risk of Primary Liver Cancer? A Case-Control Study Using the U.K. Clinical Practice Research Datalink. Hagberg KW; Sahasrabuddhe VV; McGlynn KA; Jick SS Pharmacotherapy; 2016 Feb; 36(2):187-95. PubMed ID: 26846893 [TBL] [Abstract][Full Text] [Related]
16. Effect of β blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records. Quint JK; Herrett E; Bhaskaran K; Timmis A; Hemingway H; Wedzicha JA; Smeeth L BMJ; 2013 Nov; 347():f6650. PubMed ID: 24270505 [TBL] [Abstract][Full Text] [Related]
17. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension. Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154 [TBL] [Abstract][Full Text] [Related]
18. Acetaminophen use and risk of myocardial infarction and stroke in a hypertensive cohort. Fulton RL; Walters MR; Morton R; Touyz RM; Dominiczak AF; Morrison DS; Padmanabhan S; Meredith PA; McInnes GT; Dawson J Hypertension; 2015 May; 65(5):1008-14. PubMed ID: 25801870 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of two-drug therapy versus monotherapy as initial regimen in hypertension: A propensity score-matched cohort study in the UK Clinical Practice Research Datalink. Marinier K; Macouillard P; de Champvallins M; Deltour N; Poulter N; Mancia G Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1572-1582. PubMed ID: 31482621 [TBL] [Abstract][Full Text] [Related]